BCHE and Alzheimer disease: The selective knock-down of specific variants using siRNA may also support efforts to specifically reduce the levels of cholinesterase variants that promote AD pathogenesis.42 Terminally modified ChEs are hence naturally occurring modulators of amyloid toxicity that could be harnessed in the battle against this disease.